No, right now MNKD needs UTHR to say something about what it plans to do with tre-t. It was, what, 4-5 months ago that MNKD announced they had completed phase 1 and was ready to move directly to phase 3?
Then MNKD hands over complete control to UTHR and -- poof! -- it just disappears. No word from either MNKD or UTHR about what and/or when the next step will take place.
The only thing we know is that there ten other drugs ahead of tre-t in the approval pipeline. Fat lot of good that does MNKD.
News 
Market Data 
Discover 
